FDA approves treatment IND protocol for taxol.
D017277:Drug Approval; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D017239:Paclitaxel